Miki Nagao1,2, Masaki Yamamoto3,4, Yasufumi Matsumura3,4, Isao Yokota5, Shunji Takakura3,4, Satoshi Teramukai5, Satoshi Ichiyama3,4. 1. Department of Infection Control and Prevention, Kyoto University Hospital, 54 Shogoin Kawahara-cho, Sakyo-ku, Postal code 6068507, Kyoto, Japan. mnagao@kuhp.kyoto-u.ac.jp. 2. Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. mnagao@kuhp.kyoto-u.ac.jp. 3. Department of Infection Control and Prevention, Kyoto University Hospital, 54 Shogoin Kawahara-cho, Sakyo-ku, Postal code 6068507, Kyoto, Japan. 4. Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. 5. Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Abstract
PURPOSE: Staphylococcus aureus bacteremia (SAB) is a serious clinical condition associated with high morbidity and mortality. Recent studies have revealed that adherence to evidence-based quality-of-care indicators (QCIs) for the management of SAB could result in reduced mortality. We aimed to determine whether compliance with QCIs was associated with mortality and whether compliance with QCIs predicted the mortality of patients with SAB. METHODS: In a university hospital in Kyoto, Japan, SAB patients, who survived at least 14 days after positive blood cultures were analyzed from 2006 to 2014 to assess their compliance with QCIs and the trend in mortality. In addition, the predicted mortality, which was stratified by the number of fulfilled QCIs (QCI points), was calculated. In this study, the following five main QCI points were evaluated: (1) follow-up blood cultures; (2) early source control when applicable; (3) echocardiography; (4) the early use of appropriate antibiotics, and (5) the appropriate duration of therapy. RESULTS: We identified 477 eligible SAB cases, of which 199 were MRSA cases (41.7 %). The proportion of SAB cases in which the physicians adhered to at least four QCIs increased gradually from 47.5 % in 2006 to 79.3 % in 2014 (P = 0.001); whereas, the 30-day mortality decreased from 10.0 to 3.4 % after treatment completion. CONCLUSIONS: With an increase in the proportion of SAB cases adhering to QCIs, better prognoses were observed for patients with SAB. The QCI points reflected the 30-day mortality.
PURPOSE:Staphylococcus aureus bacteremia (SAB) is a serious clinical condition associated with high morbidity and mortality. Recent studies have revealed that adherence to evidence-based quality-of-care indicators (QCIs) for the management of SAB could result in reduced mortality. We aimed to determine whether compliance with QCIs was associated with mortality and whether compliance with QCIs predicted the mortality of patients with SAB. METHODS: In a university hospital in Kyoto, Japan, SABpatients, who survived at least 14 days after positive blood cultures were analyzed from 2006 to 2014 to assess their compliance with QCIs and the trend in mortality. In addition, the predicted mortality, which was stratified by the number of fulfilled QCIs (QCI points), was calculated. In this study, the following five main QCI points were evaluated: (1) follow-up blood cultures; (2) early source control when applicable; (3) echocardiography; (4) the early use of appropriate antibiotics, and (5) the appropriate duration of therapy. RESULTS: We identified 477 eligible SAB cases, of which 199 were MRSA cases (41.7 %). The proportion of SAB cases in which the physicians adhered to at least four QCIs increased gradually from 47.5 % in 2006 to 79.3 % in 2014 (P = 0.001); whereas, the 30-day mortality decreased from 10.0 to 3.4 % after treatment completion. CONCLUSIONS: With an increase in the proportion of SAB cases adhering to QCIs, better prognoses were observed for patients with SAB. The QCI points reflected the 30-day mortality.
Entities:
Keywords:
Bacteremia; Bundle; Mortality; Quality of care; Staphylococcus aureus
Authors: M Nagao; Y Iinuma; T Saito; Y Matsumura; M Shirano; A Matsushima; S Takakura; Y Ito; S Ichiyama Journal: Clin Microbiol Infect Date: 2010-12 Impact factor: 8.067
Authors: Bharath Raj Palraj; Larry M Baddour; Erik P Hess; James M Steckelberg; Walter R Wilson; Brian D Lahr; M Rizwan Sohail Journal: Clin Infect Dis Date: 2015-03-25 Impact factor: 9.079
Authors: J O Robinson; S Pozzi-Langhi; M Phillips; J C Pearson; K J Christiansen; G W Coombs; R J Murray Journal: Eur J Clin Microbiol Infect Dis Date: 2012-03-03 Impact factor: 3.267
Authors: Timothy C Jenkins; Connie S Price; Allison L Sabel; Philip S Mehler; William J Burman Journal: Clin Infect Dis Date: 2008-04-01 Impact factor: 9.079
Authors: Jaap Ten Oever; Joëll L Jansen; Thomas W van der Vaart; Jeroen A Schouten; Marlies E J L Hulscher; Annelies Verbon Journal: J Antimicrob Chemother Date: 2019-11-01 Impact factor: 5.790
Authors: Kellie Arensman; Jennifer Dela-Pena; Jessica L Miller; Erik LaChance; Maya Beganovic; Morgan Anderson; Anne Rivelli; Sarah M Wieczorkiewicz Journal: Open Forum Infect Dis Date: 2020-05-21 Impact factor: 3.835
Authors: Kathrin Sperling; Robert Deisz; Gernot Marx; Wolfgang Greiner; Christian Juhra; Svenja Elkenkamp; Daniel Gensorowsky; Sebastian Lemmen; Jan Englbrecht; Sandra Dohmen; Antje Gottschalk; Miriam Haverkamp; Annette Hempen; Christian Flügel-Bleienheuft; Daniela Bause; Henna Schulze-Steinen; Susanne Rademacher; Jennifer Kistermann; Stefan Hoch; Hans-Juergen Beckmann; Christian Lanckohr; Volker Lowitsch; Arne Peine; Fabian Juzek-Kuepper; Carina Benstoem Journal: J Med Internet Res Date: 2022-03-02 Impact factor: 5.428